Article
Identification and validation of disulfidptosis-related signature to evaluate clinical outcomes, immune infiltration and drug sensitivity in osteosarcoma
2024-06-12
Abstract excerpt
<title>Abstract</title> <p>Disulfidptosis is a novel form of programmed cell death discovered by Liu et al. It's initiated in cells highly expressing SLC7A11, especially in cancers. Our principal aim is to establish and validate a prognostic prediction model for osteosarcoma patients, potentially providing a fresh perspective on the characteristics of disulfidptosis in osteosarcoma and its treatment. Osteosarcoma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 435da140-15b1-51f3-9a0b-7206096a5911
- DOI
- 10.21203/rs.3.rs-4426108/v1
